EPISODE · Mar 5, 2021 · 5 MIN

Tocilizumab and COVID-19

from The Lancet Respiratory Medicine in conversation with · host The Lancet Respiratory Medicine

Dr. Arvinder Soin discusses the use of tocilizumab plus standard care versus standard care alone in the treatment of moderate to severe COVID-19-associated cytokine release syndrome. Read the full article: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00081-3/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv

Episode metadata supplied by the publisher feed · Published Mar 5, 2021

Embed this episode

Attribution link and audio player

NOW PLAYING

Tocilizumab and COVID-19

0:00 5:45

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Lancet Respiratory Medicine in conversation with?

This episode is 5 minutes long.

When was this The Lancet Respiratory Medicine in conversation with episode published?

This episode was published on March 5, 2021.

Can I download this The Lancet Respiratory Medicine in conversation with episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!